<VariationArchive VariationID="656694" VariationName="NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs)" VariationType="Deletion" Accession="VCV000656694" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="627401" VariationID="656694">
      <GeneList>
        <Gene Symbol="GJC2" FullName="gap junction protein gamma 2" GeneID="57165" HGNC_ID="HGNC:17494" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="228149930" stop="228159826" display_start="228149930" display_stop="228159826" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="228337414" stop="228347526" display_start="228337414" display_stop="228347526" Strand="+" />
          </Location>
          <OMIM>608803</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs)</Name>
      <CanonicalSPDI>NC_000001.11:228158882:CGGCCTCCCTGCGGCCTCCC:CGGCCTCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="228346584" stop="228346594" display_start="228346584" display_stop="228346594" variantLength="11" positionVCF="228346583" referenceAlleleVCF="TCGGCCTCCCTG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="228158883" stop="228158893" display_start="228158883" display_stop="228158893" variantLength="11" positionVCF="228158882" referenceAlleleVCF="TCGGCCTCCCTG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A379fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.228346593_228346603del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.228346593_228346603del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.228158892_228158902del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.228158892_228158902del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011838.1" sequenceAccession="NG_011838" sequenceVersion="1" change="g.14041_14051del">
            <Expression>NG_011838.1:g.14041_14051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020435.4" sequenceAccession="NM_020435" sequenceVersion="4" change="c.1134_1144del" MANESelect="true">
            <Expression>NM_020435.4:c.1134_1144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065168.2" sequenceAccession="NP_065168" sequenceVersion="2" change="p.Ala379fs">
            <Expression>NP_065168.2:p.Ala379fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1571908452" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs) AND Spastic paraplegia" Accession="RCV000813174" Version="6">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs) AND Hypomyelinating leukodystrophy 2" Accession="RCV000986563" Version="3">
        <ClassifiedConditionList TraitSetID="527">
          <ClassifiedCondition DB="MedGen" ID="C1837355">Hypomyelinating leukodystrophy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-12-16" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020435.4(GJC2):c.1134_1144del (p.Ala379fs) AND Hereditary spastic paraplegia 44" Accession="RCV001335054" Version="1">
        <ClassifiedConditionList TraitSetID="6717">
          <ClassifiedCondition DB="MedGen" ID="C2750784">Hereditary spastic paraplegia 44</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-15" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27057822</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34055681</ID>
        </Citation>
        <DescriptionHistory Dated="2020-01-08">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="527" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5404" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PELIZAEUS-MERZBACHER-LIKE DISEASE, 1</ElementValue>
                <XRef Type="MIM" ID="608804" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 2</ElementValue>
                <XRef ID="MONDO:0012125" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PMLD1</ElementValue>
                <XRef Type="MIM" ID="608804" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HLD2</ElementValue>
                <XRef Type="MIM" ID="608804" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17293" />
                <XRef ID="17293" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pelizaeus-Merzbacher-like disease 1 (PMLD1) is a slowly progressive leukodystrophy that typically presents during the neonatal or early-infantile period with nystagmus, commonly associated with hypotonia, delayed acquisition of motor milestones, speech delay, and dysarthria. Over time the hypotonia typically evolves into spasticity that affects the ability to walk and communicate. Cerebellar signs (gait ataxia, dysmetria, intention tremor, head titubation, and dysdiadochokinesia) frequently manifest during childhood. Some individuals develop extrapyramidal movement abnormalities (choreoathetosis and dystonia). Hearing loss and optic atrophy are observed in rare cases. Motor impairments can lead to swallowing difficulty and orthopedic complications, including hip dislocation and scoliosis. Most individuals have normal cognitive skills or mild intellectual disability â€“ which, however, can be difficult to evaluate in the context of profound motor impairment.</Attribute>
                <XRef ID="NBK470716" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29276893</ID>
                <ID Source="BookShelf">NBK470716</ID>
              </Citation>
              <XRef ID="280270" DB="Orphanet" />
              <XRef ID="280282" DB="Orphanet" />
              <XRef ID="C1837355" DB="MedGen" />
              <XRef ID="MONDO:0012125" DB="MONDO" />
              <XRef Type="MIM" ID="608804" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6717" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6857" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 44</ElementValue>
                <XRef ID="MONDO:0013179" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 44, autosomal recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPG44</ElementValue>
                <XRef Type="MIM" ID="613206" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17478" />
                <XRef ID="17478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="320401" DB="Orphanet" />
              <XRef ID="C2750784" DB="MedGen" />
              <XRef ID="MONDO:0013179" DB="MONDO" />
              <XRef Type="MIM" ID="613206" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1847675" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4393440|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000953519" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27057822</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34055681</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GJC2 protein in which other variant(s) (p.Gly433Argfs*59) have been determined to be pathogenic (PMID: 27057822). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 656694). This frameshift has been observed in individual(s) with clinical features of Pelizaeus-Merzbacher disease (PMID: 34055681). This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the GJC2 gene (p.Ala379Glyfs*109). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 61 amino acid(s) of the GJC2 protein and extend the protein by 47 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.228346584_228346594del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2241381" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000001.10:g.228346584_228346594delCGGCCTCCCTG|OMIM:608804" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001135582" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.228346584_228346594delCGGCCTCCCTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608804" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3003309" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_020435.3:c.1134_1144delTGCGGCCTCCC|OMIM:613206" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001528094" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020435.3:c.1134_1144delTGCGGCCTCCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613206" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4924380" SubmissionDate="2022-05-11" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="NM_020435.4:c.1134_1144del|OMIM:608804" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002512609" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PS4 supporting, PM2 moderate, PM4 strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020435.4:c.1134_1144del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608804" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11461911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3003309" TraitType="Disease" MappingType="XRef" MappingValue="613206" MappingRef="OMIM">
        <MedGen CUI="C2750784" Name="Hereditary spastic paraplegia 44" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2241381" TraitType="Disease" MappingType="XRef" MappingValue="608804" MappingRef="OMIM">
        <MedGen CUI="C1837355" Name="Hypomyelinating leukodystrophy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1847675" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924380" TraitType="Disease" MappingType="XRef" MappingValue="608804" MappingRef="OMIM">
        <MedGen CUI="C1837355" Name="Hypomyelinating leukodystrophy 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

